Predictive biomarkers of biologic therapy response in chronic rhinosinusitis with nasal polyps: a systematic review. (PubMed, Front Med (Lausanne)) - Oct 3, 2026 - "A systematic search identified studies reporting baseline biomarkers and response to biologics (dupilumab, omalizumab, anti-IL-5 agents) in adult CRSwNP. Other biomarkers showed inconsistent predictive value across studies. PROSPERO CRD420251251904."
Biomarker • Journal • Review • Chronic Rhinosinusitis With Nasal Polyps • Immunology • Nasal Polyps • Otorhinolaryngology • Respiratory Diseases • Sinusitis • IL5
|